Abstract:Objective To study the expression of special AT-rich sequence-binding protein 1(SATB1) gene and its relationship with SLC22A18 protein expression in astrocytoma.Methods Fifty-six patients with astrocytomas (12 with grade Ⅰ,13 with grade Ⅱ,15 with grade Ⅲ,and 16 with grade Ⅳ),performed surgical excision in our hospitals from September 2006 to June 2010 and from September 2003 to June 2006,were chosen in our study; another 10 brain tissues from patients performed decompression operation resulting from cerebral hernia were selected as the controls.RT-PCR and Western blotting were used to detect the mRNA and protein expressions of SATB1.The SLC22A18 protein expression was detected by immunohistochemical assay.The relations between SLC22A18expressions and SA TB1 levels,and these two and the degree of malignancy were analyzed.Results RT-PCR and Western blotting revealed that positive mRNA and protein expressions were noted in 35patients with astrocytomas; the mRNA and protein expression rate and value of SATB1 in the astrocytoma tissues were significantly different among different grades of tumors (P＜0.05); the higher the malignancy grade,the higher mRNA and protein expression rate and value ofSA TB1; the protein expression value of SA TB1 had a positive correlation with the malignancy grade of tumors (r=0.987,P=0.000).And a few expressions of SA TB1 mRNA and protein were found in the tissues of controls.Immunohistochemical assay indicated that positive protein expression of SLC22A18 was noted in 19 astrocytoma tissues,and the protein expression rate of SLC22A18 in the astrocytoma tissues was significantly different among different grades of tumors (P＜0.05); the higher the malignancy grade,the lower expression of SLC22A18.And the protein expression of SLC22A18 was found in all the tissues of controls.The SATB1 expression rate in the tissues with negative SLC22A18 expression (81.1％) was significantly higher than that in the tissues with positive SLC22A18 expression (26.3％,P＜0.05).Conclusion SATB1 expresses in the astrocytoma tissues,indicating that it may play an important role in the pathogenesis of astrocytoma;up-regulation of SATB1 expression and dysfunction of SLC22A18 may play synergetic roles in the process of carcinogenesis of astrocytoma.

Expression of Special AT-rich Sequence-Binding Protein (SATB1) in Clear Cell Renal Carcinoma

Decreased SATB 2 Expression is Associated with Metastasis and Poor Prognosis in Human Clear Cell Renal Cell Carcinoma

Special AT-rich Sequence-Binding Protein 1 Promotes Cell Growth and Metastasis in Colorectal Cancer.

Spindle Pole Body Component 24 Homolog Potentiates Tumor Progression Via Regulation of SRY-box Transcription Factor 2 in Clear Cell Renal Cell Carcinoma.

Expression of Special AT-rich Sequence-Binding Protein and Its Clinicopathological Significance in Epithelial Ovarian Cancer

Upregulation of Serine Metabolism Enzyme PSAT1 Predicts Poor Prognosis and Promotes Proliferation, Metastasis and Drug Resistance of Clear Cell Renal Cell Carcinoma.

Expression of SATB1 in breast cancer and its relationship with clinicopathological features

Overexpression of SATB1 in laryngeal squamous cell carcinoma.

YAP-Activated SATB2 is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma

At-Rich Sequence Binding Protein 1: Contribution to Tumor Progression and Metastasis of Human Ovarian Carcinoma

SATB2 expression and its relationship with clinicopathological features in primary colorectal cancer tissues and metastatic lymph nodes

Expression of SATB1 Promotes the Growth and Metastasis of Colorectal Cancer

Expression of Special AT-rich Sequence-Binding Protein 1 Gene and Its Relationship with SLC22A18 Protein Expression in Astrocytoma

Satb1 Expression Is Correlated With Beta-Catenin Associated Epithelial-Mesenchymal Transition In Colorectal Cancer

SATB1 is Correlated with Progression and Metastasis of Breast Cancers: A Meta-Analysis.

Upregulation of SATB1 is Associated with the Development and Progression of Glioma

High SAA1 Expression Predicts Advanced Tumors in Renal Cancer

Special AT-rich Sequence Binding Protein 1 Regulates the Multidrug Resistance and Invasion of Human Gastric Cancer Cells.

SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression

Overexpression And Involvement Of Special At-Rich Sequence Binding Protein 1 In Multidrug Resistance In Human Breast Carcinoma Cells

STK4 is a prognostic biomarker correlated with immune infiltrates in clear cell renal cell carcinoma